WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011

Feb 24, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-22	Common Stock	A	11271.0000	$40.8500	Acquired	278914.9350	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-22	Stock Option (Right to Buy)	$40.8500	A	125571.0000	Acquired	2021-02-22	Common Stock (125571.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1198.6459	Indirect
Common Stock	24158.1337	Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2008 that have vested for performance period 7.